Dexcom Inc. - BDR (D1EX34)
Bovespa
Closed
Jun 25, 2026
Day's Range
7.2852 wk Range
5.75Overview - D1EX34 - Dexcom Inc. - BDR
Key Statistics
Valuation
Enterprise Value
724.45B
P/E (Trailing)
‪30.33‬
PEG Ratio
‪0.32‬
Price / Sales (TTM)
‪29.15‬
Price / Book
‪9.13‬
EV / EBITDA
‪107.89‬
Profitability
Gross Margin
‪62.94%‬
Profit Margin
‪19.31%‬
Operating Margin
‪21.42%‬
Return on Assets
‪9.65%‬
Return on Equity
‪35.62%‬
Ownership
Shares Outstanding
385.90M
Float
19.22B
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪1.44‬
50-Day Avg
‪6.74‬
200-Day Avg
‪7.07‬
Dividends
Payout Ratio
‪0.00%‬
Peers - D1EX34 - Dexcom Inc. - BDR
Peer Comparison
Compared with companies in Medical Devices listed on Bovespa.
Profile Summary - D1EX34 - Dexcom Inc. - BDR
About
Dexcom Inc. – BDR represents the Brazilian Depositary Receipts for Dexcom Inc., a leading medical device company headquartered in San Diego, California. The primary function of these BDRs is to allow Brazilian investors access to shares of Dexcom Inc. without dealing directly in foreign markets. Dexcom Inc. is…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
